| Pattern of local recurrence and distant metastasis in breast cancer by molecular subtype X Wu, A Baig, G Kasymjanova, K Kafi, C Holcroft, H Mekouar, ... Cureus 8 (12), 2016 | 98 | 2016 |
| Role of artificial intelligence in the care of patients with nonsmall cell lung cancer M Rabbani, J Kanevsky, K Kafi, F Chandelier, FJ Giles European journal of clinical investigation 48 (4), e12901, 2018 | 87 | 2018 |
| Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas DJ Betting, K Kafi, A Abdollahi-Fard, SA Hurvitz, JM Timmerman The Journal of Immunology 181 (6), 4131-4140, 2008 | 53 | 2008 |
| Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma DJ Betting, RE Yamada, K Kafi, J Said, N van Rooijen, JM Timmerman Journal of immunotherapy 32 (6), 622-631, 2009 | 48 | 2009 |
| Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells DJ Betting, XY Mu, K Kafi, D McDonnel, F Rosas, DP Gold, ... Vaccine 27 (2), 250-259, 2009 | 48 | 2009 |
| Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines K Kafi, DJ Betting, RE Yamada, M Bacica, KK Steward, JM Timmerman Molecular immunology 46 (3), 448-456, 2009 | 43 | 2009 |
| Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo SN Franki, KK Steward, DJ Betting, K Kafi, RE Yamada, JM Timmerman Blood, The Journal of the American Society of Hematology 111 (3), 1504-1511, 2008 | 36 | 2008 |
| Development of a generalizable natural language processing pipeline to extract physician-reported pain from clinical reports: generated using publicly-available datasets and … H Naseri, K Kafi, S Skamene, M Tolba, MD Faye, P Ramia, J Khriguian, ... Journal of Biomedical Informatics 120, 103864, 2021 | 19 | 2021 |
| Benchmark of data processing methods and machine learning models for gut microbiome-based diagnosis of inflammatory bowel disease R Kubinski, JY Djamen-Kepaou, T Zhanabaev, A Hernandez-Garcia, ... Frontiers in Genetics 13, 784397, 2022 | 17 | 2022 |
| Combination of cyclophosphamide, rituximab, and intratumoral CpG oligodeoxynucleotide successfully eradicates established B cell lymphoma DJ Betting, SA Hurvitz, KK Steward, RE Yamada, K Kafi, N van Rooijen, ... Journal of Immunotherapy 35 (7), 534-543, 2012 | 15 | 2012 |
| Role of digital health and artificial intelligence in inflammatory bowel disease: a scoping review K Majidova, J Handfield, K Kafi, RD Martin, R Kubinski Genes 12 (10), 1465, 2021 | 9 | 2021 |
| In Vivo Eradication of a Rituximab-Resistant Human CD20+ B Cell Lymphoma by Rituximab-CpG Oligodeoxynucleotide Conjugate Is Mediated by Natural Killer Cells and Complement. DJ Betting, K Kafi, RE Yamada, KK Steward, T Olafsen, AM Wu, ... Blood 114 (22), 723, 2009 | 5 | 2009 |
| Pattern of local recurrence and distant metastasis in breast cancer by molecular subtype. Cureus 2016; 8: e924 X Wu, A Baig, G Kasymjanova, K Kafi, C Holcroft, H Mekouar, ... PUBMED, 0 | 5 | |
| In vivo activity of rituximab-CpG oligodeoxynucleotide conjugate against rituximab-resistant human CD20+ B-cell lymphoma J Timmerman, D Betting, R Yamada, S Hurvitz, K Steward, J Said, ... Journal of Clinical Oncology 27 (15_suppl), 8529-8529, 2009 | 4 | 2009 |
| Benchmark of data processing methods and machine learning models for gut microbiome-based diagnosis of inflammatory bowel disease. Front Genet 13: 784397 R Kubinski, JY Djamen-Kepaou, T Zhanabaev, A Hernandez-Garcia, ... | 3 | 2022 |
| Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors’ response in non-small cell lung cancer: A multicenter cohort study M Tonneau, K Phan, VSK Manem, C Low-Kam, F Dutil, S Kazandjian, ... Frontiers in Oncology 13, 2023 | 2 | 2023 |
| 1394P Deep learning model to predict clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors A Elkrief, K Phan, L Di Jorio, R Simpson, M Chassé, J Malo, C Richard, ... Annals of Oncology 31, S885, 2020 | 2 | 2020 |
| 1357P A deep radiomics approach to assess PD-L1 expression and clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors … M Tonneau, K Phan, S Kazandjian, A Elkrief, J Panasci, C Richard, ... Annals of Oncology 32, S1029, 2021 | 1 | 2021 |
| Effect on in vivo immunogenicity of human idiotype-KLH vaccines by maleimide conjugation K Kafi, D Betting, R Yamada, K Steward, JM Timmerman Journal of Clinical Oncology 26 (15_suppl), 8576-8576, 2008 | 1 | 2008 |
| 1298 A weakly supervised deep learning framework to predict KRAS-STK11 and KRAS-TP53 co-mutations in lung adenocarcinomas using H&E tissue sections D Jiménez-Sánchez, C De Andrea, Á López-Janeiro, MD Lozano, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
